(Q37841616)

24 August 2017

1 reference

title

In vitro and in vivo characterizations of PEGylated liposomal doxorubicin (English)

1 reference

24 August 2017

Wenlei Jiang

1

1 reference

24 August 2017

Robert Lionberger

series ordinal

2

1 reference

24 August 2017

Lawrence X Yu

series ordinal

3

1 reference

24 August 2017

publication date

1 February 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

3

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

333-344

1 reference

Characterization of nanoparticles for therapeutics

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Nanomaterial characterization: considerations and needs for hazard assessment and safety evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

New generation of liposomal drugs for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Investigation into the role of tumor-associated macrophages in the antitumor activity of Doxil

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Stability of liposomal doxorubicin formulations: problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Atomic force microscopy: a tool to study the structure, dynamics and stability of liposomal drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Parameters influencing the determination of liposome lamellarity by 31P-NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Perturbing effects of carvedilol on a model membrane system: role of lipophilicity and chemical structure

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Calorimetry and cryo-transmission electron microscopic studies of PEG2000-grafted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

A quantitative model for using acridine orange as a transmembrane pH gradient probe.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Liposome size analysis by dynamic/static light scattering upon size exclusion-/field flow-fractionation

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Characterization of loaded liposomes by size exclusion chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

The influence of nano MgO and BaSO4 particle size additives on properties of PMMA bone cement

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Polymer vesicles in vivo: correlations with PEG molecular weight

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Hydration of polyethylene glycol-grafted liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Characterization and cytotoxicity of mixed polyethyleneglycol modified liposomes containing doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

1H NMR quantification of poly(ethylene glycol)-phosphatidylethanolamine in phospholipid mixtures.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Application of NMR spectroscopy to the characterization of PEG-stabilized lipid nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Liposome-encapsulated prednisolone phosphate inhibits growth of established tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged <3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Separation of liposome-associated doxorubicin from non-liposome-associated doxorubicin in human plasma: implications for pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Determination of free and liposome-associated daunorubicin and daunorubicinol in plasma by capillary electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Determination of free and liposomal amphotericin B in human plasma by liquid chromatography-mass spectroscopy with solid phase extraction and protein precipitation techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Simultaneous analysis of liposomal doxorubicin and doxorubicin using capillary electrophoresis and laser induced fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Rapid acidification of endocytic vesicles containing alpha 2-macroglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FBIO.10.204

21 January 2018

Identifiers

DOI

10.4155/BIO.10.204

1 reference

24 August 2017

1 reference